Electronic clinical outcome assessment (eCOA) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing at a CAGR of 15.8% in the forecast period of 2020 to 2027 and expected to reach USD 1,114.55 million by 2027. Highly developed healthcare infrastructure capable of adopting updated technologies in North American countries is boosting the market growth in the region.
Get Sample Copy Of North America Electronic Clinical Outcome Assessment (eCOA) Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-electronic-clinical-outcome-assessment-ecoa-market
The major players covered in the report are Oracle, Parexel International Corporation, ERT Clinical, Bioclinica, IBM Corporation, eClinical Solutions LLC, ArisGlobal LLC, Signant Health, Medidata, Omnicomm Systems, Inc., YPrime, LLC, Clinical Ink, WIRB-Copernicus Group among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
North America Electronic Clinical Outcome Assessment (eCOA) Market Scope and Market Size
North America electronic clinical outcome assessment (eCOA) market is segmented on the basis of product, approach, end user and platform. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
On the basis of product, the market is segmented into on-premise solutions, cloud based solutions and web based solutions. In North America, the on-premise solutions segment is dominating due to high volume of existing eCOA solutions being used by end users.
On the basis of approach, the market is segmented into clinician reported outcome assessment (CLINRO), patient reported outcome assessment (PRO), observer reported outcome assessment (OBSRO) and performance outcome assessment (PERFO). In North America, clinician reported outcome assessment (CLINRO) is dominating as it is a crucial stage of the clinical trial study where end points of the study are defined by professionals.
On the basis of end user, the market is segmented into commercial service providers, hospitals and transplant centers and research laboratories and academic institutions. In North America, commercial service providers are dominating due to the trend of outsourcing of clinical trials.
On the basis of platform, the market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, medical device manufacturers, hospitals and clinical laboratories, consulting service companies, research and academia and others. In North America, contract research organizations are dominating in the market as they offer a broad variety of services in one facility where the sponsor need not worry about the processes.
Table of Contents
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
9. Industry Type
Get detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=north-america-electronic-clinical-outcome-assessment-ecoa-market
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected]
. We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: [email protected]